Latin America Cardiac Resynchronization Therapy Study (LatAmCRT)
Heart Failure.
About this trial
This is an interventional treatment trial for Heart Failure.
Eligibility Criteria
Inclusion Criteria: Implant of new CRT-D or CRT-P device (first-time implant), ACC/AHA/HRS/ESC guidelines for implant, NYHA Class II, III or IV, QRS duration >120 ms, LVEF < 35%, Receiving optimal medical/drug therapy, Able to give written informed consent, Are > 21 years of age, Must be able to return for follow-up visits as required, Are not pregnant or do not plan to get pregnant within the next 6 months, Have no physical limitations to perform Echo studies
Exclusion Criteria: Previous or existing CRT system implanted, Unwilling or unable to comply with specified follow-up schedule, Enrolled or intending to participate in another device study during the course of this study that requires specific treatment or device programming, Medical condition that may limit life expectancy to < 6 months
Sites / Locations
- Hospital Angeles Tijuana
- Hospital Angeles Leon
Arms of the Study
Arm 1
No Intervention
No intervention
Mostly observational study with 1 patient global assessment.